Thymidine Kinase 2 Deficiency (TK2d) Treatments
Find Thymidine Kinase 2 Deficiency (TK2d) Treatments
Medications for Thymidine Kinase 2 Deficiency (TK2d)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Thymidine Kinase 2 Deficiency (TK2d).
Found 1 Approved Drug for Thymidine Kinase 2 Deficiency (TK2d)
Kygevvi
Generic Name
Doxribtimine
Kygevvi
Generic Name
Doxribtimine
Form: Powder
Method of administration: Oral
FDA approval date: November 10, 2025
KYGEVVI is indicated for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years. KYGEVVI is a combination of doxecitine and doxribtimine, both pyrimidine nucleosides, indicated for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years. ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances